Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

BIL vs IBB: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, BIL returned +3.7% to IBB's +37.5%, and BIL charges 0.14% to IBB's 0.44%.

askIQ about this page

askIQ about BIL and IBB

Net assets on Oct 27, 2026: $48.7bn for SPDR Bloomberg 1-3 Month T-Bill ETF and $11.0bn for iShares Biotechnology ETF.

At a glance
+3.7%
BIL total return, 1 year
+37.5%
IBB total return, 1 year
0.14%
BIL expense ratio
0.44%
IBB expense ratio

Pair scorecard

BIL costs 0.30 points a year less; their one-year returns differ by 33.8 points; BIL is 4.4 times larger.

BIL vs IBB: Differences, Returns & Fees
MeasureBILIBB
Return
Total return, 1 year+3.7%+37.5%
Benchmark
What it tracksBloomberg 1-3 Month U.S. Treasury Bill IndexBiotech
Cost and size
Expense ratio0.14%0.44%
Net assets, as of Oct 27, 2026$48.7bn$11.0bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
In the S&P 500, by weight40%
Top ten holdings, share of the fund50%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, BIL and IBB hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first BIL IBB
Only in one fund ↓
Only in BIL
TREASURY BILL 12/26 0.00000 7.94%
TREASURY BILL 12/26 0.00000 6.66%
TREASURY BILL 12/26 0.00000 6.46%
TREASURY BILL 12/26 0.00000 6.40%
TREASURY BILL 12/26 0.00000 6.39%
TREASURY BILL 11/26 0.00000 6.26%
TREASURY BILL 12/26 0.00000 6.21%
TREASURY BILL 11/26 0.00000 4.85%
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Check overlap with more funds →

Side by side

BIL SPDR Bloomberg 1-3 Month T-Bill ETF IBB iShares Biotechnology ETF
Where it sits Bond ETF Thematic ETF
What it is Tracks an index of 1-3 month T-bills Biotech
Total return, 1 year +3.7% +37.5%
Expense ratio 0.14% 0.44%
Holdings 26 245
Net assets, as of Oct 27, 2026 $48.7bn $11.0bn

BIL and IBB on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

BIL and IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
BIL

BIL tracks an index of 1-3 month T-bills. Over the year to Oct 28, 2026 it returned +3.7% with distributions reinvested. The prospectus expense ratio is 0.14% a year.

IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

Questions people ask

Are BIL and IBB in the same category?
BIL is a bond ETF and IBB is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, BIL or IBB?
In the year to Oct 28, 2026, with distributions reinvested, BIL returned +3.7% and IBB +37.5%.
Which is cheaper, BIL or IBB?
BIL is cheaper, by 0.30 percentage points a year. That is about $30 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, BIL against IBB, data as of Oct 28, 2026. https://etfiq.com/compare/any/bil-vs-ibb

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.